| II-56 Paul Thoueille Population pharmacokinetic modelling to characterize the effect of chronic kidney disease on tenofovir exposure after tenofovir alafenamide administration Wednesday 15:10-16:40 |
| II-56 Paul Thoueille Population pharmacokinetic modelling to characterize the effect of chronic kidney disease on tenofovir exposure after tenofovir alafenamide administration Wednesday 15:10-16:40 |